Journal article · 2026

Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed

Chris Baraniuk

BMJ, 395, e101250 · Published 27 October 2026 · DOI 10.1136/bmj-2026-101250

View at the publisherCite this paper

In brief

“Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed” is a 2026 journal article by Chris Baraniuk, published in BMJ. OpenAlex counts 2 citations as of 16 November 2026, which puts it in the top 5% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
7.17
References
1
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Baraniuk, C. (2026). Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed. BMJ, 395, e101250. https://doi.org/10.1136/bmj-2026-101250

MLA 9

Baraniuk, Chris. “Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed.” BMJ, vol. 395, 2026, p. e101250. https://doi.org/10.1136/bmj-2026-101250.

Chicago

Baraniuk, Chris. 2026. “Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed.” BMJ 395: e101250. https://doi.org/10.1136/bmj-2026-101250.

Harvard

Baraniuk, C. (2026) ‘Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed’, BMJ, 395, p. e101250. doi:10.1136/bmj-2026-101250.

IEEE

C. Baraniuk, “Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed,” BMJ, vol. 395, p. e101250, 2026, doi: 10.1136/bmj-2026-101250.

BibTeX

@article{baraniuk2026ebola,
  title     = {{Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed}},
  author    = {Baraniuk, Chris},
  journal   = {BMJ},
  year      = {2026},
  volume    = {395},
  pages     = {e101250},
  doi       = {10.1136/bmj-2026-101250},
  url       = {https://doi.org/10.1136/bmj-2026-101250}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research

  • Ebola virus disease
  • Bundibugyo virus
  • Ebola vaccine
  • vaccine clinical trials
  • vaccine safety

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Baraniuk, C. (2026). Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed. BMJ, 395, e101250. https://doi.org/10.1136/bmj-2026-101250

How many times has this paper been cited?

2 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Chris Baraniuk.

What is the DOI of this paper?

10.1136/bmj-2026-101250, permanently at https://doi.org/10.1136/bmj-2026-101250. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.